These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 23199207)
1. Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer. Lin TY; Li YP; Zhang H; Luo J; Goodwin N; Gao T; White Rde V; Lam KS; Pan CX Nanomedicine (Lond); 2013 Aug; 8(8):1239-51. PubMed ID: 23199207 [TBL] [Abstract][Full Text] [Related]
2. Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer. Lin TY; Zhang H; Luo J; Li Y; Gao T; Lara PN; de Vere White R; Lam KS; Pan CX Int J Nanomedicine; 2012; 7():2793-804. PubMed ID: 22745542 [TBL] [Abstract][Full Text] [Related]
3. Disulfide-crosslinked nanomicelles confer cancer-specific drug delivery and improve efficacy of paclitaxel in bladder cancer. Pan A; Zhang H; Li Y; Lin TY; Wang F; Lee J; Cheng M; Dall'Era M; Li T; deVere White R; Pan CX; Lam KS Nanotechnology; 2016 Oct; 27(42):425103. PubMed ID: 27640312 [TBL] [Abstract][Full Text] [Related]
4. Paclitaxel incorporated in hydrophobically derivatized hyperbranched polyglycerols for intravesical bladder cancer therapy. Mugabe C; Hadaschik BA; Kainthan RK; Brooks DE; So AI; Gleave ME; Burt HM BJU Int; 2009 Apr; 103(7):978-86. PubMed ID: 19007363 [TBL] [Abstract][Full Text] [Related]
5. Paclitaxel loaded hyaluronic acid nanoparticles for targeted cancer therapy: in vitro and in vivo analysis. Thomas RG; Moon M; Lee S; Jeong YY Int J Biol Macromol; 2015 Jan; 72():510-8. PubMed ID: 25224289 [TBL] [Abstract][Full Text] [Related]
6. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel. Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643 [TBL] [Abstract][Full Text] [Related]
7. Paclitaxel-loaded gelatin nanoparticles for intravesical bladder cancer therapy. Lu Z; Yeh TK; Tsai M; Au JL; Wientjes MG Clin Cancer Res; 2004 Nov; 10(22):7677-84. PubMed ID: 15570001 [TBL] [Abstract][Full Text] [Related]
8. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion. Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386 [TBL] [Abstract][Full Text] [Related]
9. Hydrophobically modified inulin as an amphiphilic carbohydrate polymer for micellar delivery of paclitaxel for intravenous route. Muley P; Kumar S; El Kourati F; Kesharwani SS; Tummala H Int J Pharm; 2016 Mar; 500(1-2):32-41. PubMed ID: 26792170 [TBL] [Abstract][Full Text] [Related]
10. Development and evaluation of well-tolerated and tumor-penetrating polymeric micelle-based dry powders for inhaled anti-cancer chemotherapy. Rosière R; Van Woensel M; Mathieu V; Langer I; Mathivet T; Vermeersch M; Amighi K; Wauthoz N Int J Pharm; 2016 Mar; 501(1-2):148-59. PubMed ID: 26850313 [TBL] [Abstract][Full Text] [Related]
11. Selective tissue distribution and long circulation endowed by paclitaxel loaded PEGylated poly(ε-caprolactone-co-L-lactide) micelles leading to improved anti-tumor effects and low systematic toxicity. Wang F; Shen Y; Xu X; Lv L; Li Y; Liu J; Li M; Guo A; Guo S; Jin F Int J Pharm; 2013 Nov; 456(1):101-12. PubMed ID: 23968782 [TBL] [Abstract][Full Text] [Related]
12. c(RGDfK) decorated micellar drug delivery system for intravesical instilled chemotherapy of superficial bladder cancer. Zhou D; Zhang G; Gan Z J Control Release; 2013 Aug; 169(3):204-10. PubMed ID: 23388072 [TBL] [Abstract][Full Text] [Related]
13. Effect of dimethyl sulfoxide on bladder tissue penetration of intravesical paclitaxel. Chen D; Song D; Wientjes MG; Au JL Clin Cancer Res; 2003 Jan; 9(1):363-9. PubMed ID: 12538489 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of a paclitaxel-binding polymeric micelle for efficient breast cancer therapy. Xiang J; Wu B; Zhou Z; Hu S; Piao Y; Zhou Q; Wang G; Tang J; Liu X; Shen Y Sci China Life Sci; 2018 Apr; 61(4):436-447. PubMed ID: 29572777 [TBL] [Abstract][Full Text] [Related]
15. "OA02" peptide facilitates the precise targeting of paclitaxel-loaded micellar nanoparticles to ovarian cancer in vivo. Xiao K; Li Y; Lee JS; Gonik AM; Dong T; Fung G; Sanchez E; Xing L; Cheng HR; Luo J; Lam KS Cancer Res; 2012 Apr; 72(8):2100-10. PubMed ID: 22396491 [TBL] [Abstract][Full Text] [Related]
16. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery. Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876 [TBL] [Abstract][Full Text] [Related]
17. Systemic delivery of micelles loading with paclitaxel using N-succinyl-palmitoyl-chitosan decorated with cRGDyK peptide to inhibit non-small-cell lung cancer. Yuan ZQ; Li JZ; Liu Y; Chen WL; Yang SD; Zhang CG; Zhu WJ; Zhou XF; Liu C; Zhang XN Int J Pharm; 2015 Aug; 492(1-2):141-51. PubMed ID: 26188316 [TBL] [Abstract][Full Text] [Related]
18. Pluronic-based functional polymeric mixed micelles for co-delivery of doxorubicin and paclitaxel to multidrug resistant tumor. Chen Y; Zhang W; Huang Y; Gao F; Sha X; Fang X Int J Pharm; 2015 Jul; 488(1-2):44-58. PubMed ID: 25899286 [TBL] [Abstract][Full Text] [Related]
19. The use of α-conotoxin ImI to actualize the targeted delivery of paclitaxel micelles to α7 nAChR-overexpressing breast cancer. Mei D; Lin Z; Fu J; He B; Gao W; Ma L; Dai W; Zhang H; Wang X; Wang J; Zhang X; Lu W; Zhou D; Zhang Q Biomaterials; 2015 Feb; 42():52-65. PubMed ID: 25542793 [TBL] [Abstract][Full Text] [Related]